Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Rheumatol ; 19(12): 1874-84, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1294734

ABSTRACT

The probability of continuation of a particular nonsteroidal antiinflammatory drug (NSAID) over 5 years was estimated for 1,775 courses taken by 532 patients with rheumatoid arthritis treated in 7 rheumatology private practices. Similar results were seen for 15 different NSAID--48% of courses were continued at 12 months, 36% at 24 months, and 20% at 60 months. Only acetylated salicylates, other than plain aspirin, were continued significantly longer than any of the other NSAID. The probability of continuation of plain aspirin was similar to other NSAID, including nonacetylated salicylates and nonsalicylate NSAID. The first NSAID taken by an individual patient was continued only marginally longer than the 4th NSAID taken by the same patient. While most NSAID courses were not continued for long periods, 20% were continued for longer than 5 years, suggesting effective longterm results in this minority of courses.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Arthritis, Rheumatoid/drug therapy , Private Practice , Aspirin/therapeutic use , Female , Humans , Indomethacin/therapeutic use , Ketoprofen/therapeutic use , Long-Term Care , Male , Meclofenamic Acid/therapeutic use , Middle Aged , Surveys and Questionnaires
2.
J Rheumatol ; 19(12): 1885-94, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1294735

ABSTRACT

The probability of continuation of 1,077 courses of 2nd line drugs taken by 532 patients with rheumatoid arthritis treated in 7 rheumatology private practices was examined. This probability was that 50% of courses were continued over 10 months for oral gold, 20 months for hydroxychloroquine, 21 months for penicillamine, 25 months for parenteral gold, 27 months for azathioprine, and more than 60 months for methotrexate (MTX). MTX and prednisone were the only drugs continued by more than 50% of patients after 60 months, while about 20% of courses of other 2nd line drugs other than oral gold were estimated to be continued at 60 months. Estimated drug continuation did not differ significantly according to age, duration of disease, or whether the drug was the first, second, or 3rd 2nd line drug used. Some patients took each 2nd line drug for more than 5 years, suggesting a favorable experience, but most courses were not continued beyond 2 years.


Subject(s)
Arthritis, Rheumatoid/drug therapy , Gold/therapeutic use , Hydroxychloroquine/therapeutic use , Prednisone/therapeutic use , Private Practice , Age Factors , Azathioprine/therapeutic use , Drug Therapy, Combination , Humans , Long-Term Care , Methotrexate/therapeutic use , Middle Aged , Penicillamine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...